Cancer immunotherapy & APC biology
The science
behind the system
Recent immunotherapy progress, the barriers that remain, and the DC–antigen–T cell relationship that underlies antigen-specific research.
Read the narration transcript
Dendritic cells connect antigen detection with T cell responses. At their contact site, called the immunological synapse, several molecular interactions work together.
A peptide displayed by an HLA molecule engages a compatible T cell receptor. Class I presentation is recognized by CD8 T cells. Class II presentation is recognized by CD4 T cells.
Recognition alone does not explain the full response. CD80 and CD86 can engage CD28, while adhesion molecules help maintain contact. Signals then travel into the T cell.
Activated helper T cells can provide CD40 ligand to dendritic cells. Cytokines shape the response. IL-12 can favor type 1 immunity. IL-2 supports T cell growth, with its source depending on the experimental context.
Inhibitory interactions also matter. PD-L1 binding PD-1 can reduce T cell signaling. Activation reflects the balance of antigen recognition, costimulation, cytokines and inhibitory signals.
For drug discovery, measure more than cell numbers. Test antigen and HLA dependence, cytokine responses, and activity against paired target cells. These complementary readouts connect the mechanism to the biological question.